Cite
HARVARD Citation
Kazi, A. et al. (2020). Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity. Journal of steroid biochemistry and molecular biology. p. . [Online].